FrancophonIA/ELRC3.0 huggingface dataset:
English: Very common side effects (may affect more than 1 in 10 people): - breathing problems (including shortness of breath), - feeling depressed, - trouble sleeping, thinking or concentrating, dizziness, - severe stomach pain or cramps, - fever or chills beginning after a few weeks of treatment, - painful or inflamed muscles (sometimes severe),
Slovenian: Zelo pogosti neželeni učinki (pojavijo se lahko pri več kot 1 od 10 bolnikov): - težave z dihanjem (vključno s kratko sapo), - depresija, - težave s spanjem, mišljenjem ali koncentracijo, omotica, - hude želodčne bolečine ali krči, - zvišana telesna temperatura ali mrzlica, ki se začne po nekaj tednih zdravljenja, - bolečine v mišicah ali vnetje mišic (včasih hudo).
English: Co-administration of thioridazine with the product (PegIntron) may increase the blood concentrations of thioridazine.
Slovenian: Sočasna uporaba tioridazina z zdravilom PegIntron lahko zviša koncentracije tioridazina v krvi.
English: No pharmacokinetic interactions were noted between PegIntron and ribavirin in a multiple-dose pharmacokinetic study.
Slovenian: V študiji uporabe večkratnih odmerkov niso opažali nikakršnih farmakokinetičnih interakcij med zdravilom PegIntron in ribavirinom.
English: PegIntron - ampoule of solvent
Slovenian: PegIntron - ampula vehikla
English: a: p value based on Cochran-Mantel Haenszel Chi square test. b: p value based on chi-square test. c: subjects < 75 kg received 100 µg/week PegIntron and subjects ≥ 75 kg received 150 µg/week PegIntron.
Slovenian: mio i.e. = milijonov mednarodnih enot a: vrednost p na podlagi Cochran-Mantel Haenszelovega hi-kvadrat testa b: vrednost p na podlagi hi-kvadrat testa c: preiskovanci s telesno maso < 75 kg so prejemali 100 µg zdravila PegIntron na teden, preiskovanci s telesno maso ≥ 75 kg pa so prejemali 150 µg zdravila PegIntron na teden d: odmerek ribavirina je znašal 800 mg za bolnike s telesno maso < 60 kg, 1.000 mg za bolnike s telesno maso 60 - 75 kg in 1200 mg za tiste s telesno maso > 75 kg
English: Monotherapy with PegIntron and bitherapy with PegIntron and ribavirin Naïve patients
Slovenian: Monoterapija z zdravilom PegIntron in dvojna terapija z zdravilom PegIntron in ribavirinom: Predhodno nezdravljeni bolniki
English: When patients are administered PegIntron with medications metabolized by CYP1A2 or CYP2D6, the extent of the decrease in cytochrome P 450 activity is unlikely to have a clinical impact, except with medicines which have a narrow therapeutic margin (Table 5).
Slovenian: Obseg zmanjšanja aktivnosti citokroma P 450 verjetno nima kliničnega vpliva, kadar bolniki sočasno prejmejo zdravilo PegIntron in zdravila, ki se presnovijo s CYP1A2 ali CYP2D6, razen pri zdravilih z ozkim terapevtskim oknom (preglednica 5).
English: 9/l, and
Slovenian: 9/l in
English: PegIntron plus ribavirin
Slovenian: Zdravilo PegIntron plus ribavirin
English: - Dissolve the entire contents by swirling the PegIntron vial with a gentle rotary motion leaving the needle and attached syringe in the vial.
Slovenian: Da boste raztopili celotno vsebino viale zdravila PegIntron, jo nežno obračajte skupaj z iglo na brizgi, ki je še v viali, dokler ne bo vsebina viale popolnoma raztopljena.
English: Table 3c Reduced PegIntron dose (0.5 g/kg) for the 1.0 g/kg monotherapy regimen in adults Body weight (kg)
Slovenian: Preglednica 3c Zmanjšani odmerek zdravila PegIntron (0,5 g/kg) pri monoterapiji z 1,0 g/kg pri odraslih bolnikih
English: In patients with moderate renal dysfunction (creatinine clearance 30-50 ml/minute), the starting dose of PegIntron should be reduced by 25 %.
Slovenian: Pri bolnikih z zmernimi motnjami delovanja ledvic (očistek kreatinina od 30 do 50 ml/minuto) začetni odmerek zdravila PegIntron zmanjšajte za 25 %, pri tistih s hudimi motnjami delovanja ledvic (očistek kreatinina od 15 do 29 ml/minuto) pa morate začetni odmerek zdravila PegIntron zmanjšati za 50 %.
English: The pharmacokinetics of PegIntron following a single subcutaneous dose of 1.0 microgram/kg were not affected by age.
Slovenian: Starost ni vplivala na farmakokinetiko zdravila PegIntron po enkratnem subkutanem odmerku 1,0 mikrogram/kg.
English: Amount of PegIntron to administer (µg)
Slovenian: Količina zdravila PegIntron za uporabo (µg)
English: weakness, - difficult breathing, pharyngitis (sore throat), coughing, - stomach pain, vomiting, nausea, diarrhoea, loss of appetite, loss of weight, dry mouth, - hair loss, itching, dry skin, rash, irritation or redness (and rarely, skin damage) at the site of injection, - decreases in the number of red blood cells (that may cause fatigue, shortness of breath,
Slovenian: - bolečine v želodcu, bruhanje, siljenje na bruhanje, driska, izguba apetita, hujšanje, suha usta, - izpadanje las, srbenje, suha koža, izpuščaj, draženje ali pordelost (in redko poškodbe kože) na mestu injiciranja, - zmanjšanje števila rdečih krvnih celic (ki lahko povzroči utrujenost, kratko sapo, omotico),
English: Predictability of sustained virological response - Naïve patients: Virological response by week 12 is defined as at least 2-log viral load decrease or undetectable levels of HCV-RNA.
Slovenian: Napoved trajnega virološkega odziva - Predhodno nezdravljeni bolniki Virološki odziv do 12. tedna je opredeljen kot zmanjšanje virusnega bremena za vsaj 2 logaritemski enoti ali nemerljiva koncentracija HCV-RNA.
English: Metabolism of theophylline is suppressed by inhibitory action of the product (PegIntron) on CYP1A2.
Slovenian: Zaviralni učinek zdravila PegIntron na CYP1A2 upočasni presnovo teofilina.
English: SVR after treatment of chronic HCV with PegIntron (with or without ribavirin) results in long-term clearance of the virus providing resolution of the hepatic infection and clinical “cure” from chronic HCV.
Slovenian: Doseganje trajnega virološkega odziva po zdravljenju kroničnega HCV z zdravilom PegIntron (z ali brez ribavirina) vodi do dolgoročne odstranitve virusa, s čimer zagotovimo odpravo jetrne okužbe in klinično "ozdravitev" kronične okužbe s HCV, vendar pri bolnikih s cirozo jeter seveda ni izključeno kasnejše pojavljanje različnih jetrnih težav (na primer karcinoma jeter).
English: Patients were randomized to receive either PegIntron (100 or 150 µg/week based on weight) plus ribavirin (800-1,200 mg/day based on weight) or interferon alfa-2b (3 MIU TIW) plus ribavirin (800-1,200 mg/day based on weight).
Slovenian: Bolnike so naključno razporedili bodisi v skupino, ki je prejemala zdravilo PegIntron (100 ali 150 µg/teden glede na telesno maso) in ribavirin (8001.200 mg/dan glede na telesno maso), ali pa v skupino, ki je prejemala interferon alfa-2b (3 milijone i.e. trikrat na teden) in ribavirin (800-1.200 mg/dan glede na telesno maso).
English: After administering the dose, discard the PegIntron pre-filled pen (CLEARCLICK) and any unused solution contained in it.
Slovenian: Po uporabi neporabljene ostanke napolnjenega injekcijskega peresnika PegIntron (CLEARCLICK) in raztopino, ki je ostala v njem, zavrzite.
English: Therefore, each vial contains an extra amount of solvent and PegIntron powder to ensure delivery of the labeled dose in 0.5 ml of PegIntron, solution for injection.
Slovenian: Zato vsaka viala vsebuje dodatno količino vehikla in praška PegIntron, da zagotovimo dajanje odmerka, ki je naveden na nalepki, v 0,5 ml zdravila PegIntron, raztopina za injiciranje.
English: Common side effects (may affect up to 1 in 10 people): chest pain, changes in the way your heart beats, confusion, difficulty remaining alert, numbness or tingling feeling, pain in your lower back or side, difficulty or inability to pass urine, problems with your eyes or your eyesight or hearing, severe or painful reddening of your skin or mucous membrane, severe bleeding from your nose, gums or any other part of your body.
Slovenian: Pogosti neželeni učinki (pojavijo se lahko pri največ 1 od 10 bolnikov): bolečine v prsih, spremenjen srčni utrip, zmedenost, težave ostati buden, občutek omrtvičenosti ali mravljincev, bolečine v križu ali ob strani, težave pri uriniranju ali nezmožnost uriniranja, težave z očmi, vidom ali sluhom, močna ali boleča pordelost kože ali sluznic, hude krvavitve iz nosu, dlesni, ali katerega koli drugega dela telesa.
English: PegIntron 1.5 micrograms/kg
Slovenian: PegIntron 1,5 mikrograma/kg
English: PegIntron (100 or c µg/week) + ribavirin
Slovenian: PegIntron (100 ali µg/teden) + ribavirin mg)
English: PegIntron is supplied as: - 1 vial of powder for solution for injection and 1 ampoule of solvent for parenteral use; - 1 vial of powder for solution for injection, 1 ampoule of solvent for parenteral use, 1 injection syringe, 2 injection needles and 1 cleansing swab; - 4 vials of powder for solution for injection and 4 ampoules of solvent for parenteral use; - 4 vials of powder for solution for injection, 4 ampoules of solvent for parenteral use, 4 injection syringes, 8 injection needles and 4 cleansing swabs; - 6 vials of powder for solution for injection and 6 ampoules of solvent for parenteral use.
Slovenian: PegIntron je na voljo v naslednjih pakiranjih: - 1 viala s praškom za raztopino za injiciranje in 1 ampula z vehiklom za parenteralno uporabo, - 1 viala s praškom za raztopino za injiciranje, 1 ampula z vehiklom za parenteralno uporabo, 1 injekcijska brizga, 2 injekcijski igli in 1 čistilni tampon, - 4 viale s praškom za raztopino za injiciranje in 4 ampule z vehiklom za parenteralno uporabo, - 4 viale s praškom za raztopino za injiciranje, 4 ampule z vehiklom za parenteralno uporabo, 4 injekcijske brizge, 8 injekcijskih igel in 4 čistilni tamponi, - 6 vial s praškom za raztopino za injiciranje in 6 ampul z vehiklom za parenteralno uporabo, - 12 vial s praškom za raztopino za injiciranje, 12 ampul z vehiklom za parenteralno uporabo, 12 injekcijskih brizg, 24 injekcijskih igel in 12 čistilnih tamponov.
English: - Interferon alfa-2b (3 MIU three times a week) + ribavirin (1,000/1,200 mg/day) (n = 505).
Slovenian: + ribavirin (1.000/1.200 mg/dan) (n = 514) - Interferon alfa-2b (3 mio i.e. 3-krat na teden) + ribavirin (1.000/1.200 mg/dan) (n = 505)
English: Therefore, each pre-filled pen contains an excess amount of solvent and PegIntron powder to ensure delivery of the labelled dose in 0.5 ml of PegIntron, solution for injection.
Slovenian: Zato vsak napolnjen injekcijski peresnik vsebuje dodatno količino vehikla in praška PegIntron, da zagotovimo dajanje odmerka, ki je naveden na nalepki, v 0,5 ml zdravila PegIntron, raztopina za injiciranje.
English: SVR % (n/N) 99 % CI
Slovenian: tednu % (n/N) 99 % IZ 99 % IZ
English: Careful co-administration of theophylline with the product (PegIntron) is recommended.
Slovenian: Pri sočasni uporabi teofilina z zdravilom PegIntron je potrebna previdnost.
English: Volume of PegIntron to administer (ml)
Slovenian: Volumen zdravila PegIntron za injiciranje (ml)
English: PegIntron is injected subcutaneously after reconstituting the powder as instructed, attaching a needle and setting the prescribed dose.
Slovenian: Po rekonstituciji praška v skladu z navodili, postavitvi igle na peresnik in nastavitvi predpisanega odmerka se zdravilo PegIntron injicira subkutano.
English: Please refer to the ribavirin and boceprevir Summary of Product Characteristics (SmPCs) when PegIntron is to be used in combination with these medicines.
Slovenian: V primeru uporabe zdravila PegIntron z ribavirinom in boceprevirjem, prosimo, glejte Povzetka glavnih značilnosti zdravila (SmPC) za ti dve zdravili.
English: Please refer to the ribavirin SmPC when PegIntron is to be used in combination with ribavirin.
Slovenian: V primeru uporabe zdravila PegIntron v kombinaciji z ribavirinom, prosimo, glejte SmPC za ribavirin.
English: 2 injection needles and 1 cleansing swab; - 4 vials of powder for solution for injection and 4 ampoules of solvent for injection; - 4 vials of powder for solution for injection, 4 ampoules of solvent for injection, 4 injection syringes, 8 injection needles and 4 cleansing swabs; - 6 vials of powder for solution for injection and 6 ampoules of solvent for injection; - 12 vials of powder for solution for injection, 12 ampoules of solvent for injection, 12 injection syringes, 24 injection needles and 12 cleansing swabs.
Slovenian: Zdravilo PegIntron je na voljo v različnih velikostih pakiranj: - 1 viala praška za raztopino za injiciranje in 1 ampula vehikla za injiciranje; - 1 viala praška za raztopino za injiciranje, 1 ampula vehikla za injiciranje, 1 injekcijska brizga, 2 injekcijski igli in 1 čistilni tampon; - 4 viale praška za raztopino za injiciranje in 4 ampule vehikla za injiciranje; - 4 viale praška za raztopino za injiciranje, 4 ampule vehikla za injiciranje, 4 injekcijske brizge, 8 injekcijskih igel in 4 čistilni tamponi; - 6 vial praška za raztopino za injiciranje in 6 ampul vehikla za injiciranje; - 12 vial praška za raztopino za injiciranje in 12 ampul vehikla za injiciranje, 12 injekcijskih brizg, 24 injekcijskih igel in 12 čistilnih tamponov.
English: The lowest PegIntron strength available is 50 g/0.5 ml; therefore for patients prescribed 0.5 g/kg/week, doses must be adjusted by volume as shown in Table 2.
Slovenian: Bolnikom, ki jim predpišete odmerek 0,5 g/kg/teden, morate torej volumsko prilagoditi odmerek, kot je prikazano v preglednici 2.
English: Tell your doctor or healthcare professional or the doctor or healthcare professional of the child you are caring for as soon as possible.
Slovenian: Če ste uporabili večji odmerek zdravila PegIntron, kot bi smeli Čimprej povejte zdravniku ali zdravstvenemu delavcu ali zdravniku ali zdravstvenemu delavcu otroka, za katerega skrbite.
English: PegIntron 80 micrograms powder and solvent for solution for injection EU/1/00/131/006
Slovenian: PegIntron 80 mikrogramov prašek in vehikel za raztopino za injiciranje EU/1/00/131/006
English: PegIntron 120 micrograms powder and solvent for solution for injection EU/1/00/131/016
Slovenian: PegIntron 120 mikrogramov prašek in vehikel za raztopino za injiciranje EU/1/00/131/016
English: PegIntron monotherapy - Adults
Slovenian: Monoterapija z zdravilom PegIntron - odrasli bolniki Odmerek za injiciranje
English: PegIntron 150 micrograms - vial of powder
Slovenian: PegIntron 150 mikrogramov - viala praška
English: nd dose reduction of PegIntron is to 20 g/m 2/week.
Slovenian: Najmanjša jakost zdravila PegIntron je 50 g/0,5 ml.
English: PegIntron 150 micrograms powder and solvent for solution for injection EU/1/00/131/021
Slovenian: PegIntron 150 mikrogramov prašek in vehikel za raztopino za injiciranje EU/1/00/131/021
English: PegIntron 120 micrograms - vial of powder
Slovenian: PegIntron 120 mikrogramov - viala praška
English: PegIntron 80 micrograms - vial of powder
Slovenian: PegIntron 80 mikrogramov - viala praška
English: Very common side effects (may affect more than 1 in 10 people): - feeling depressed, irritability, trouble falling asleep or staying asleep, feeling anxious or nervous, difficulty concentrating, mood swings, - headache, dizziness, tired feeling, shaking chills, fever, flu-like symptoms, virus infection,
Slovenian: Zelo pogosti (pojavijo se lahko pri več kot 1 od 10 bolnikov): - depresija, razdražljivost, težave z uspavanjem ali zbujanje, tesnoba ali živčnost, težave s koncentracijo, nihanje razpoloženja, - glavobol, omotica, občutek utrujenosti, mrzlica s tresenjem, zvišana telesna temperatura, gripi podobni simptomi, virusna okužba, šibkost, - oteženo dihanje, faringitis (vneto grlo), kašelj,
English: The following treatment-related adverse reactions were reported in adults in clinical trials or through post-marketing surveillance in patients treated with peginterferon alfa-2b, including PegIntron monotherapy or PegIntron/ribavirin.
Slovenian: Med zdravljenjem so v času kliničnih preizkušanj ali v obdobju spremljanja zdravila na trgu pri odraslih bolnikih zdravljenih s peginterferonom alfa-2b, vključno z monoterapijo z zdravilom PegIntron ali s kombinirano terapijo z zdravilom PegIntron in ribavirinom poročali o naslednjih neželenih učinkih, povezanih z zdravljenjem.
English: Dental and periodontal disorders, which may lead to loss of teeth, have been reported in patients receiving PegIntron and ribavirin combination therapy.
Slovenian: Pri bolnikih, ki so prejemali zdravilo PegIntron z ribavirinom v kombinirani terapiji, so poročali o boleznih zob in obzobnega tkiva, ki lahko vodijo do izgube zob.
English: - pain in joints and muscles, muscle and bone pain.
Slovenian: bolečine v kosteh, mišična šibkost
English: if you are a girl or a woman of childbearing age who is taking ribavirin: you must have a negative pregnancy test before treatment, each month during treatment, and for the 4 months after treatment is stopped.
Slovenian: Test nosečnosti mora biti pri vas negativen pred zdravljenjem, vsak mesec med zdravljenjem in še 4 mesece po zaključku zdravljenja.
English: How to store PegIntron
Slovenian: Shranjevanje zdravila PegIntron
English: PegIntron 50 micrograms powder and solvent for solution for injection EU/1/00/131/001
Slovenian: PegIntron 50 mikrogramov prašek in vehikel za raztopino za injiciranje EU/1/00/131/001
English: PegIntron 100 micrograms powder and solvent for solution for injection EU/1/00/131/011
Slovenian: PegIntron 100 mikrogramov prašek in vehikel za raztopino za injiciranje EU/1/00/131/011
English: PegIntron 50 micrograms - vial of powder
Slovenian: PegIntron 50 mikrogramov - viala praška
English: PegIntron 50 micrograms powder and solvent for solution for injection in pre-filled pen PegIntron 80 micrograms powder and solvent for solution for injection in pre-filled pen PegIntron 100 micrograms powder and solvent for solution for injection in pre-filled pen PegIntron 120 micrograms powder and solvent for solution for injection in pre-filled pen PegIntron 150 micrograms powder and solvent for solution for injection in pre-filled pen peginterferon alfa-2b
Slovenian: PegIntron 50 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku PegIntron 80 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku PegIntron 100 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku PegIntron 120 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku PegIntron 150 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku peginterferon alfa-2b
English: Careful co-administration of thioridazine with the product (PegIntron) is recommended.
Slovenian: Pri sočasni uporabi tioridazina z zdravilom PegIntron je potrebna previdnost.
English: PegIntron contains sucrose
Slovenian: Zdravilo PegIntron vsebuje saharozo
English: PegIntron 100 micrograms - vial of powder
Slovenian: PegIntron 100 mikrogramov - viala praška
English: PegIntron 50 micrograms powder and solvent for solution for injection PegIntron 80 micrograms powder and solvent for solution for injection PegIntron 100 micrograms powder and solvent for solution for injection PegIntron 120 micrograms powder and solvent for solution for injection PegIntron 150 micrograms powder and solvent for solution for injection peginterferon alfa-2b
Slovenian: PegIntron 50 mikrogramov prašek in vehikel za raztopino za injiciranje PegIntron 80 mikrogramov prašek in vehikel za raztopino za injiciranje PegIntron 100 mikrogramov prašek in vehikel za raztopino za injiciranje PegIntron 120 mikrogramov prašek in vehikel za raztopino za injiciranje PegIntron 150 mikrogramov prašek in vehikel za raztopino za injiciranje peginterferon alfa-2b
English: PegIntron 50 micrograms powder and solvent for solution for injection PegIntron 80 micrograms powder and solvent for solution for injection PegIntron 100 micrograms powder and solvent for solution for injection PegIntron 120 micrograms powder and solvent for solution for injection PegIntron 150 micrograms powder and solvent for solution for injection
Slovenian: PegIntron 50 mikrogramov prašek in vehikel za raztopino za injiciranje PegIntron 80 mikrogramov prašek in vehikel za raztopino za injiciranje PegIntron 100 mikrogramov prašek in vehikel za raztopino za injiciranje PegIntron 120 mikrogramov prašek in vehikel za raztopino za injiciranje PegIntron 150 mikrogramov prašek in vehikel za raztopino za injiciranje
English: Both the Metavir score and Ishak grade decreased among subjects treated with PegIntron in combination with ribavirin.
Slovenian: Pri preiskovancih, zdravljenih z zdravilom PegIntron v kombinaciji z ribavirinom, sta se zmanjšali tako ocena po Metavirju kot ocena po Ishaku.
English: EU/1/00/131/008 (4 vials of powder, 4 ampoules of solvent) EU/1/00/131/009 (4 vials of powder, 4 ampoules of solvent, 4 injection syringes, 8 injection needles and 4 cleansing swabs)
Slovenian: EU/1/00/131/008 (4 viale praška, 4 ampule vehikla) EU/1/00/131/009 (4 viale praška, 4 ampule vehikla, 4 injekcijske brizge, 8 injekcijskih igel, 4 čistilni tamponi)
English: The pharmacokinetics of PegIntron have not been evaluated in patients with severe hepatic dysfunction.
Slovenian: Okvara jeter Pri bolnikih s hudo jetrno okvaro farmakokinetike zdravila PegIntron niso ocenjevali.
English: The following treatment-related adverse reactions were reported in the study in children and adolescent patients treated with PegIntron in combination with ribavirin.
Slovenian: V študiji pri otrocih in mladostnikih, zdravljenih z zdravilom PegIntron v kombinaciji z ribavirinom, so poročali o naslednjih z zdravljenjem povezanih neželenih učinkih.
English: EU/1/00/131/003 (4 vials of powder, 4 ampoules of solvent) EU/1/00/131/004 (4 vials of powder, 4 ampoules of solvent, 4 injection syringes, 8 injection needles and 4 cleansing swabs)
Slovenian: EU/1/00/131/003 (4 viale praška, 4 ampule vehikla) EU/1/00/131/004 (4 viale praška, 4 ampule vehikla, 4 injekcijske brizge, 8 injekcijskih igel, 4 čistilni tamponi)
English: Package inserts of theophylline should be referred to when co-administering with the product (PegIntron)
Slovenian: Pri sočasni uporabi z zdravilom PegIntron je treba upoštevati navodilo za uporabo teofilina.
English: PegIntron 80 micrograms powder and solvent for solution for injection Each vial is to be reconstituted with 0.7 ml of water for injections for administration of up to 0.5 ml of solution.
Slovenian: PegIntron 80 mikrogramov prašek in vehikel za raztopino za injiciranje Eno vialo se rekonstituira z 0,7 ml vode za injekcije za dajanje do 0,5 ml raztopine.
English: Pen label - PegIntron 120 micrograms powder and solvent for solution for injection in pre-filled pen
Slovenian: Nalepka na peresniku - PegIntron 120 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku
English: Pen label - PegIntron 150 micrograms powder and solvent for solution for injection in pre-filled pen
Slovenian: Nalepka na peresniku - PegIntron 150 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku
English: Metabolism of thioridazine is suppressed by inhibitory action of the product (PegIntron) on CYP2D6.
Slovenian: Zaviralni učinek zdravila PegIntron na CYP2D6 upočasni presnovo tioridazina.
English: Also see SmPCs for ribavirin and boceprevir if PegIntron is to be administered in combination therapy in patients with chronic hepatitis C.
Slovenian: Pri uporabi zdravila PegIntron v kombinirani terapiji pri bolnikih s kroničnim hepatitisom C glejte tudi SmPC za ribavirin in boceprevir.
English: EU/1/00/131/011 (1 vial of powder, 1 ampoule of solvent) EU/1/00/131/012 (1 vial of powder, 1 ampoule of solvent, 1 injection syringe, 2 injection needles and 1 cleansing swab)
Slovenian: EU/1/00/131/011 (1 viala praška, 1 ampula vehikla) EU/1/00/131/012 (1 viala praška, 1 ampula vehikla, 1 injekcijska brizga, 2 injekcijski igli, 1 čistilni tampon)
English: Pen label - PegIntron 50 micrograms powder and solvent for solution for injection in pre-filled pen
Slovenian: Nalepka na peresniku - PegIntron 50 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku
English: st dose reduction of PegIntron is to 40 g/m 2/week, 2
Slovenian: Začetni odmerek 60 g/m2/teden zmanjšate na 40 g/m2/teden in nato na